Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Brenda Ng, PhD
Gilead Sciences, Inc.
Disclosure(s): Gilead Sciences, Inc.: Employee, Stocks/Bonds (Public Company)
Poster(s):
(P-387) Evaluation of Treatment Satisfaction and Experiences Among People With HIV When Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide From Cabotegravir + Rilpivirine: Results From the Phase 4 EMPOWER Study
Monday, October 20, 2025
12:15 PM - 1:30 PM
US ET
